vs
Avantor, Inc.（AVTR）与Burlington Stores, Inc.（BURL）财务数据对比。点击上方公司名可切换其他公司
Burlington Stores, Inc.的季度营收约是Avantor, Inc.的1.6倍（$2.7B vs $1.7B），Burlington Stores, Inc.净利率更高（3.9% vs 3.1%，领先0.7%），Burlington Stores, Inc.同比增速更快（7.1% vs -1.4%），Avantor, Inc.自由现金流更多（$117.2M vs $-109.6M），过去两年Avantor, Inc.的营收复合增速更高（-0.5% vs -6.9%）
Avantor是一家总部位于美国宾夕法尼亚州拉德诺的生物技术、化工及制药领域企业，前身为1904年成立的J.T. Baker，2010年正式更名，2019年在纽约证券交易所挂牌上市，股票代码为AVTR，为全球生命科学、医疗健康等行业客户提供核心产品与服务。
伯灵顿百货（前身为伯灵顿大衣厂）是美国知名全国性折扣零售商，在全美46个州及波多黎各拥有超过1138家门店，总部位于新泽西州伯灵顿镇。2007年公司被贝恩资本收购，2008年汤姆·金斯伯里出任总裁兼首席执行官，2013年重新上市，现为美国第三大折扣零售企业。
AVTR vs BURL — 直观对比
营收规模更大
BURL
是对方的1.6倍
$1.7B
营收增速更快
BURL
高出8.5%
-1.4%
净利率更高
BURL
高出0.7%
3.1%
自由现金流更多
AVTR
多$226.8M
$-109.6M
两年增速更快
AVTR
近两年复合增速
-6.9%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $2.7B |
| 净利润 | $52.4M | $104.8M |
| 毛利率 | 31.5% | 44.2% |
| 营业利润率 | 7.6% | 5.1% |
| 净利率 | 3.1% | 3.9% |
| 营收同比 | -1.4% | 7.1% |
| 净利润同比 | -89.5% | 15.6% |
| 每股收益（稀释后） | $0.08 | $1.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVTRBURL
| Q4 25 | $1.7B | $2.7B | ||
| Q3 25 | $1.6B | $2.7B | ||
| Q2 25 | $1.7B | $2.5B | ||
| Q1 25 | $1.6B | $3.3B | ||
| Q4 24 | $1.7B | $2.5B | ||
| Q3 24 | $1.7B | $2.5B | ||
| Q2 24 | $1.7B | $2.4B | ||
| Q1 24 | $1.7B | $3.1B |
净利润AVTRBURL
| Q4 25 | $52.4M | $104.8M | ||
| Q3 25 | $-711.8M | $94.2M | ||
| Q2 25 | $64.7M | $100.8M | ||
| Q1 25 | $64.5M | $260.8M | ||
| Q4 24 | $500.4M | $90.6M | ||
| Q3 24 | $57.8M | $73.8M | ||
| Q2 24 | $92.9M | $78.5M | ||
| Q1 24 | $60.4M | $227.5M |
毛利率AVTRBURL
| Q4 25 | 31.5% | 44.2% | ||
| Q3 25 | 32.4% | 43.7% | ||
| Q2 25 | 32.9% | 43.8% | ||
| Q1 25 | 33.8% | 42.9% | ||
| Q4 24 | 33.4% | 43.9% | ||
| Q3 24 | 32.9% | 42.8% | ||
| Q2 24 | 34.1% | 43.5% | ||
| Q1 24 | 34.0% | 42.7% |
营业利润率AVTRBURL
| Q4 25 | 7.6% | 5.1% | ||
| Q3 25 | -40.0% | 4.7% | ||
| Q2 25 | 7.7% | 5.3% | ||
| Q1 25 | 9.3% | 10.6% | ||
| Q4 24 | 37.8% | 4.7% | ||
| Q3 24 | 7.3% | 4.0% | ||
| Q2 24 | 10.3% | 4.7% | ||
| Q1 24 | 8.7% | 10.0% |
净利率AVTRBURL
| Q4 25 | 3.1% | 3.9% | ||
| Q3 25 | -43.8% | 3.5% | ||
| Q2 25 | 3.8% | 4.0% | ||
| Q1 25 | 4.1% | 8.0% | ||
| Q4 24 | 29.7% | 3.6% | ||
| Q3 24 | 3.4% | 3.0% | ||
| Q2 24 | 5.5% | 3.3% | ||
| Q1 24 | 3.6% | 7.3% |
每股收益（稀释后）AVTRBURL
| Q4 25 | $0.08 | $1.63 | ||
| Q3 25 | $-1.04 | $1.47 | ||
| Q2 25 | $0.09 | $1.58 | ||
| Q1 25 | $0.09 | $4.03 | ||
| Q4 24 | $0.73 | $1.40 | ||
| Q3 24 | $0.08 | $1.15 | ||
| Q2 24 | $0.14 | $1.22 | ||
| Q1 24 | $0.09 | $3.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $365.4M | $584.1M |
| 总债务越低越好 | $3.9B | $2.0B |
| 股东权益账面价值 | $5.6B | $1.5B |
| 总资产 | $11.8B | $9.6B |
| 负债/权益比越低杠杆越低 | 0.71× | 1.32× |
8季度趋势，按日历期对齐
现金及短期投资AVTRBURL
| Q4 25 | $365.4M | $584.1M | ||
| Q3 25 | $251.9M | $747.6M | ||
| Q2 25 | $449.4M | $371.1M | ||
| Q1 25 | $315.7M | $994.7M | ||
| Q4 24 | $261.9M | $857.8M | ||
| Q3 24 | $285.3M | $659.9M | ||
| Q2 24 | $272.6M | $742.3M | ||
| Q1 24 | $234.9M | $925.4M |
总债务AVTRBURL
| Q4 25 | $3.9B | $2.0B | ||
| Q3 25 | $3.9B | $2.0B | ||
| Q2 25 | $4.2B | $1.6B | ||
| Q1 25 | $4.1B | $1.5B | ||
| Q4 24 | $4.1B | $1.5B | ||
| Q3 24 | $4.9B | $1.2B | ||
| Q2 24 | $5.1B | $1.2B | ||
| Q1 24 | $5.3B | $1.4B |
股东权益AVTRBURL
| Q4 25 | $5.6B | $1.5B | ||
| Q3 25 | $5.6B | $1.4B | ||
| Q2 25 | $6.3B | $1.4B | ||
| Q1 25 | $6.1B | $1.4B | ||
| Q4 24 | $6.0B | $1.1B | ||
| Q3 24 | $5.6B | $1.1B | ||
| Q2 24 | $5.4B | $1.0B | ||
| Q1 24 | $5.3B | $996.9M |
总资产AVTRBURL
| Q4 25 | $11.8B | $9.6B | ||
| Q3 25 | $11.7B | $9.3B | ||
| Q2 25 | $12.8B | $8.5B | ||
| Q1 25 | $12.3B | $8.8B | ||
| Q4 24 | $12.1B | $8.4B | ||
| Q3 24 | $12.8B | $7.8B | ||
| Q2 24 | $12.7B | $7.7B | ||
| Q1 24 | $12.8B | $7.7B |
负债/权益比AVTRBURL
| Q4 25 | 0.71× | 1.32× | ||
| Q3 25 | 0.69× | 1.40× | ||
| Q2 25 | 0.67× | 1.21× | ||
| Q1 25 | 0.67× | 1.12× | ||
| Q4 24 | 0.68× | 1.35× | ||
| Q3 24 | 0.89× | 1.15× | ||
| Q2 24 | 0.94× | 1.20× | ||
| Q1 24 | 1.00× | 1.40× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $152.7M | $143.3M |
| 自由现金流经营现金流 - 资本支出 | $117.2M | $-109.6M |
| 自由现金流率自由现金流/营收 | 7.0% | -4.1% |
| 资本支出强度资本支出/营收 | 2.1% | 9.3% |
| 现金转化率经营现金流/净利润 | 2.91× | 1.37× |
| 过去12个月自由现金流最近4个季度 | $495.0M | $-358.5M |
8季度趋势，按日历期对齐
经营现金流AVTRBURL
| Q4 25 | $152.7M | $143.3M | ||
| Q3 25 | $207.4M | $179.4M | ||
| Q2 25 | $154.4M | $-28.9M | ||
| Q1 25 | $109.3M | $543.2M | ||
| Q4 24 | $173.3M | $110.4M | ||
| Q3 24 | $244.8M | $160.4M | ||
| Q2 24 | $281.1M | $49.4M | ||
| Q1 24 | $141.6M | $598.5M |
自由现金流AVTRBURL
| Q4 25 | $117.2M | $-109.6M | ||
| Q3 25 | $171.7M | $-101.0K | ||
| Q2 25 | $124.8M | $-438.6M | ||
| Q1 25 | $81.3M | $189.8M | ||
| Q4 24 | $145.8M | $-56.2M | ||
| Q3 24 | $204.0M | $-35.2M | ||
| Q2 24 | $235.3M | $-115.5M | ||
| Q1 24 | $106.9M | $410.3M |
自由现金流率AVTRBURL
| Q4 25 | 7.0% | -4.1% | ||
| Q3 25 | 10.6% | -0.0% | ||
| Q2 25 | 7.4% | -17.5% | ||
| Q1 25 | 5.1% | 5.8% | ||
| Q4 24 | 8.6% | -2.2% | ||
| Q3 24 | 11.9% | -1.4% | ||
| Q2 24 | 13.8% | -4.9% | ||
| Q1 24 | 6.4% | 13.1% |
资本支出强度AVTRBURL
| Q4 25 | 2.1% | 9.3% | ||
| Q3 25 | 2.2% | 6.6% | ||
| Q2 25 | 1.8% | 16.4% | ||
| Q1 25 | 1.8% | 10.8% | ||
| Q4 24 | 1.6% | 6.6% | ||
| Q3 24 | 2.4% | 7.9% | ||
| Q2 24 | 2.7% | 7.0% | ||
| Q1 24 | 2.1% | 6.0% |
现金转化率AVTRBURL
| Q4 25 | 2.91× | 1.37× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | 2.39× | -0.29× | ||
| Q1 25 | 1.69× | 2.08× | ||
| Q4 24 | 0.35× | 1.22× | ||
| Q3 24 | 4.24× | 2.18× | ||
| Q2 24 | 3.03× | 0.63× | ||
| Q1 24 | 2.34× | 2.63× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVTR
| Laboratory Solutions Segment | $1.1B | 67% |
| Bioscience Production Segment | $547.5M | 33% |
BURL
暂无分部数据
